Over the last two decades, there has been a significant change in oncological treatment. The paradigm that dominated the medical approach for years has been replaced by a new perspective that places the patient at the center of therapeutic decisions.
Previously, the central question was to determine which treatment was most appropriate for a given disease. This standardized approach treated all patients with the same pathology similarly, following defined protocols for each type of cancer.
Currently, the focus has shifted to the individual patient. The fundamental question is now which treatment is most appropriate for each person, considering their specific characteristics, such as genetics, medical history, and other personal factors.
This transformation represents a significant paradigm shift in hematology and oncology in general, allowing for more effective treatments tailored to each patient.
